Nordea Investment Management AB increased its position in shares of Sabra Health Care REIT, Inc. (NASDAQ: SBRA – Get a rating) by 3.1% in the 1st quarter, Participation channel reports. The company held 550,620 shares of the real estate investment trust after acquiring an additional 16,663 shares during the period. Nordea Investment Management AB’s holdings in Sabra Health Care REIT were worth $8,254,000 at the end of the last reporting period.
Other hedge funds have also recently changed their positions in the business. Bank of America Corp DE increased its stake in Sabra Health Care REIT by 40.6% during the fourth quarter. Bank of America Corp DE now owns 335,561 shares of the real estate investment trust valued at $4,543,000 after acquiring 96,846 additional shares last quarter. State of New Jersey Common Pension Fund D increased its stake in Sabra Health Care REIT by 10.3% during the fourth quarter. New Jersey State Joint Pension Fund D now owns 298,512 shares of the real estate investment trust worth $4,042,000 after acquiring 27,980 additional shares last quarter. Wolverine Asset Management LLC increased its stake in Sabra Health Care REIT by 673.7% during the fourth quarter. Wolverine Asset Management LLC now owns 140,418 shares of the real estate investment trust worth $1,901,000 after acquiring an additional 122,270 shares last quarter. The New York State Teachers Retirement System increased its stake in Sabra Health Care REIT by 2.3% during the fourth quarter. The New York State Teachers’ Retirement System now owns 316,583 shares of the real estate investment trust valued at $4,287,000 after acquiring an additional 7,227 shares in the last quarter. Finally, Janney Montgomery Scott LLC increased its stake in Sabra Health Care REIT by 9.5% during the fourth quarter. Janney Montgomery Scott LLC now owns 95,632 shares of the real estate investment trust valued at $1,295,000 after acquiring 8,314 additional shares in the last quarter. Hedge funds and other institutional investors own 91.61% of the company’s shares.
SBRA action opened at $14.67 on Friday. Sabra Health Care REIT, Inc. has a 12-month low of $11.44 and a 12-month high of $19.01. The company has a current ratio of 3.60, a quick ratio of 3.60 and a debt ratio of 0.70. The company has a 50-day moving average price of $13.23 and a 200-day moving average price of $13.48. The stock has a market capitalization of $3.39 billion, a PE ratio of -29.94 and a beta of 1.42.
Sabra Healthcare REIT (NASDAQ: SBRA – Get a rating) last released its quarterly results on Wednesday, May 4. The real estate investment trust reported EPS of $0.18 for the quarter, beating analyst consensus estimates of $0.17 by $0.01. Sabra Health Care REIT posted a negative net margin of 18.28% and a negative return on equity of 3.15%. In the same quarter a year earlier, the company posted earnings per share of $0.39. Sell-side analysts expect Sabra Health Care REIT, Inc. to post EPS of 1.48 for the current year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, May 31. Investors of record on Monday, May 16 received a dividend of $0.30 per share. The ex-dividend date was Friday, May 13. This represents a dividend of $1.20 on an annualized basis and a dividend yield of 8.18%. Sabra Health Care REIT’s dividend payout ratio is currently -244.89%.
SBRA has been the subject of several research analyst reports. Barclays cut shares of Sabra Health Care REIT from an “overweight” rating to a “weighted” rating and reduced its target price for the company from $16.00 to $14.00 in a Monday 18 research note. april. Credit Suisse Group raised its price target on shares of Sabra Health Care REIT from $14.00 to $15.00 and gave the stock a “neutral” rating in a Monday, April 4 research note. Capital One Financial began covering shares of Sabra Health Care REIT in a research note on Friday, June 3. They issued an “equal weight” rating and a price target of $15.50 for the company. StockNews.com began covering shares of Sabra Health Care REIT in a research note on Thursday, March 31. They issued a “holding” rating for the company. Finally, Mizuho moved shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and lowered its price target for the stock from $16.00 to $15.00 in a note. research on Wednesday, May 25. Six equity research analysts gave the stock a hold rating and five gave the company a buy rating. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $16.06.
Profile of Sabra Healthcare REIT (Get a rating)
As of March 31, 2022, Sabra’s investment portfolio included 416 properties held for investment. These include (i) 279 skilled nursing/transitional care facilities, (ii) 59 senior housing communities (senior residences – leased), (iii) 50 senior housing communities operated by third-party property managers pursuant to property management agreements (retirement homes – managed), (iv) 13 behavioral health facilities and (v) 15 specialty hospitals and other facilities), an asset held for sale, an investment in a lease-purchase, 16 investments in loans receivable (including (i) two mortgage loans, (ii) a construction loan and (iii) 13 other loans), seven investments in preferred shares and an investment in a unconsolidated joint venture.
Get news and reviews for Sabra Health Care REIT Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Sabra Health Care REIT and related companies with MarketBeat.com’s free daily email newsletter.